Stent Patients with High Platelet Reactivity Had Twice the Rate of Cardiovascular Events

SAN DIEGO, CA  – Accumetrics, Inc., developer of the VerifyNow® System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, today announced that results from a patient-level meta-analysis of more than 3,000 stent patients have been published in the Journal of the American College of Cardiology1. Read More…

Observed Clinical Activity Suggests OTO-104 Provides Clinically Meaningful Reduction in Vertigo Frequency and Improvement in Tinnitus

San Diego, CA – Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced that researchers presented positive new data from a Phase 1b study of the company’s lead product candidate, OTO-104, in patients with Ménière’s disease. Read More…

PALO ALTO, CA and SEATTLE, WA – Varian Medical Systems, Inc., (NYSE:VAR) and Calypso Medical Technologies, Inc., today announced they have signed a definitive agreement under which Varian will acquire Calypso, a privately-owned, Seattle-based developer and supplier of specialized products and software for real-time tumor tracking and motion management during radiosurgery and radiotherapy. Read More…

Clinical Role of Platelet Reactivity Testing Gains Additional Support with Third Guideline Recommendation by a Medical Society in 2011

SAN DIEGO, CA – Accumetrics, Inc., developer of the VerifyNow® System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, announced today that a new recommendation (IIb-B) to consider platelet function testing has been incorporated in the European Society of Cardiology (ESC) Guidelines. Read More…